New study aims to crack the code on Hard-to-Diagnose cartilage tumors

NCT ID NCT07315542

First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study looks for better ways to diagnose and treat cartilage tumors, especially a type of bone cancer called chondrosarcoma. Researchers will study genetic changes and other molecules in tumor samples from 300 people to tell benign from malignant tumors and predict outcomes. The goal is to create more accurate tests and find new targets for therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROSARCOMAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia

    RECRUITING

    Brno, South Moravian, 60200, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.